Jaguar Health, Inc. (NASDAQ:JAGX) (”Jaguar” or “the Company”), today announced the closing of its previously announced private placement.

Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected ...

Jaguar Health shares are trading lower by 30.7% during Tuesday's session. The company announced a 1-for-25 reverse stock split of its common stock. Jaguar Health shares are trading lower by 15.4% ...

increased approximately 13% versus net Q3 2024 revenue of $3.1 million and 53% versus net Q4 2023 revenue of $2.3 million Jaguar expects first results in Q2 2025 of proof-of-concept (POC ...